CLGN

About CollPlant Biotechnologies Ltd Ordinary Shares (CLGN) Stock

CollPlant Biotechnologies Ltd Ordinary Shares (CLGN) closed the 2026-09-17 session at $4.16, up 19.54% versus the previous close (+0.68). The stock opened at $3.51 and traded between $3.50 and $4.20 during that session. Session trading volume was 183K shares. The volume-weighted average price (VWAP) is $3.92.

CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives majority revenue, Canada, Europe and Other, and Israel.

CollPlant Biotechnologies Ltd Ordinary Shares has a market capitalization of $6.6 million. CLGN is listed on the XNAS exchange. The company employs approximately 39 people. The recorded listing date is 2021-06-04.

On this page you can find market CLGN stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.

Explore more: View today's market movers, use the stock screener, or browse all sectors.